{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:25:58Z","timestamp":1788830758945,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,4]]},"DOI":"10.7759\/cureus.68621","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:56:21Z","timestamp":1725447381000},"source":"Crossref","is-referenced-by-count":2,"title":["Oxaliplatin Antibody-Related Thrombocytopenia: A Case Report"],"prefix":"10.7759","author":[{"given":"Khin","family":"Pyai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I","family":"LeRoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Attallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zyad","family":"Kafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9 T","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, et al.. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004, 350:2343-51. 10.1056\/NEJMoa032709","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds074","article-title":"Oxaliplatin-related thrombocytopenia","volume":"23","author":"Jardim DL","year":"2012","unstructured":"Jardim DL, Rodrigues CA, Novis YA, Rocha VG, Hoff PM. Oxaliplatin-related thrombocytopenia. Ann Oncol. 2012, 23:1937-42. 10.1093\/annonc\/mds074","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2014.052","article-title":"Oxaliplatin-induced immune-mediated thrombocytopenia: a case report","volume":"47","author":"Woo HS","year":"2015","unstructured":"Woo HS, Lee KH, Yoon PH, et al.. Oxaliplatin-induced immune-mediated thrombocytopenia: a case report. Cancer Res Treat. 2015, 47:949-53. 10.4143\/crt.2014.052","journal-title":"Cancer Res Treat"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-3-12","article-title":"Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature","volume":"3","author":"Bautista MA","year":"2010","unstructured":"Bautista MA, Stevens WT, Chen CS, Curtis BR, Aster RH, Hsueh CT. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. J Hematol Oncol. 2010, 3:12. 10.1186\/1756-8722-3-12","journal-title":"J Hematol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20516","article-title":"Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin","volume":"81","author":"Curtis BR","year":"2006","unstructured":"Curtis BR, Kaliszewski J, Marques MB, et al.. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol. 2006, 81:193-8. 10.1002\/ajh.20516","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.154056","article-title":"Oxaliplatin-induced acute thrombocytopenia","volume":"12","author":"Erdem GU","year":"2016","unstructured":"Erdem GU, Dogan M, Demirci NS, Zengin N. Oxaliplatin-induced acute thrombocytopenia. J Cancer Res Ther. 2016, 12:509-14. 10.4103\/0973-1482.154056","journal-title":"J Cancer Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George JN","year":"1998","unstructured":"George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998, 129:886-90. 10.7326\/0003-4819-129-11_part_1-199812010-00009","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2013.05.005","article-title":"Approach to the diagnosis and management of drug-induced immune thrombocytopenia","volume":"27","author":"Arnold DM","year":"2013","unstructured":"Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013, 27:137-45. 10.1016\/j.tmrv.2013.05.005","journal-title":"Transfus Med Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2020.07.007","article-title":"Oxaliplatin-induced immune thrombocytopenia: a case report and literature review","volume":"20","author":"Stack A","year":"2021","unstructured":"Stack A, Khanal R, Denlinger CS. Oxaliplatin-induced immune thrombocytopenia: a case report and literature review. Clin Colorectal Cancer. 2021, 20:e1-4. 10.1016\/j.clcc.2020.07.007","journal-title":"Clin Colorectal Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster RH","year":"2007","unstructured":"Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007, 357:580-7. 10.1056\/NEJMra066469","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-024-01059-x","article-title":"Risk factors of chemotherapy-induced thrombocytopenia after oxaliplatin-containing chemotherapy for gastrointestinal malignancies","volume":"55","author":"Li J","year":"2024","unstructured":"Li J, Wang W, Jiang K, et al.. Risk factors of chemotherapy-induced thrombocytopenia after oxaliplatin-containing chemotherapy for gastrointestinal malignancies. J Gastrointest Cancer. 2024, 55:1144-53. 10.1007\/s12029-024-01059-x","journal-title":"J Gastrointest Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/249091-oxaliplatin-antibody-related-thrombocytopenia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:56:24Z","timestamp":1725447384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/249091-oxaliplatin-antibody-related-thrombocytopenia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.68621","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}